|
|
|||
|
||||
OverviewOriginally published in 1981, this comprehensive volume is intended for medical economists, clinical pharmacologists, physicians, pharmacists and consumers, as well as planner and administrators who must determine relevant policy and legislation in the area of the provision of medicines. The contributors believe that the system of drugs provision can benefit from being studied, by policy revisions and evaluation of the outcomes of policy operations. Full Product DetailsAuthor: Richard Blum , Andrew Herxheimer , Catherine Stenzl , Jasper WoodcockPublisher: Taylor & Francis Ltd Imprint: Routledge Weight: 0.508kg ISBN: 9781032252216ISBN 10: 1032252219 Pages: 272 Publication Date: 30 June 2024 Audience: General/trade , College/higher education , General , Tertiary & Higher Education Format: Paperback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviews'The book is a positive contribution to the literature...It is amply documented through a bountiful list of references and additional readings of truly international scope.' Albert I. Wertheimer, College of Pharmacy, University of Minnesota, USA. Author InformationRichard Blum was Chairman of the International Research Group for Drug Legislation and Programs. Andrew Herxheimer was a consultant at the Charing Cross Hospital in London and Professor of Pharmacology at the University of Groningen, The Netherlands. Catherine Stenzl was Coordinator of the International Research Group for Drug Legislation and Programs. Jasper Woodcock was Director of the Institute for the Study of Drug Dependence London. Tab Content 6Author Website:Countries AvailableAll regions |